ICU Medical, Inc. ICUI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 560.44M | 551.68M | 530.23M | 540.70M | 536.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 560.44M | 551.68M | 530.23M | 540.70M | 536.99M |
| Cost of Revenue | 336.09M | 335.53M | 324.00M | 337.72M | 336.11M |
| Gross Profit | 224.35M | 216.15M | 206.23M | 202.99M | 200.88M |
| SG&A Expenses | 154.41M | 151.92M | 154.57M | 155.81M | 152.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 512.25M | 510.15M | 499.85M | 514.62M | 510.13M |
| Operating Income | 48.19M | 41.53M | 30.38M | 26.09M | 26.86M |
| Income Before Tax | 34.04M | 26.16M | -4.58M | -18.39M | -4.05M |
| Income Tax Expenses | 7.19M | 7.07M | -34.71M | -2.65M | -658.00K |
| Earnings from Continuing Operations | 26.85M | 19.09M | 30.13M | -15.73M | -3.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.85M | 19.09M | 30.13M | -15.73M | -3.40M |
| EBIT | 48.19M | 41.53M | 30.38M | 26.09M | 26.86M |
| EBITDA | 97.79M | 91.14M | 80.41M | 76.92M | 77.66M |
| EPS Basic | 1.07 | 0.76 | 1.22 | -0.64 | -0.14 |
| Normalized Basic EPS | 0.70 | 0.73 | 0.31 | 0.12 | 0.19 |
| EPS Diluted | 1.07 | 0.76 | 1.20 | -0.64 | -0.14 |
| Normalized Diluted EPS | 0.69 | 0.73 | 0.31 | 0.12 | 0.19 |
| Average Basic Shares Outstanding | 25.01M | 25.00M | 24.76M | 24.69M | 24.69M |
| Average Diluted Shares Outstanding | 25.15M | 25.04M | 25.18M | 24.69M | 24.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |